<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01912313</url>
  </required_header>
  <id_info>
    <org_study_id>S55484</org_study_id>
    <nct_id>NCT01912313</nct_id>
  </id_info>
  <brief_title>Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)</brief_title>
  <official_title>Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rectal biopsies from IBS patients or healthy subjects will be taken.

      Biopsies will be used for:

        1. the isolation of submucosal plexus to perform: 1.1 live nerve recordings and Calcium
           imaging; 1.2 immunohistochemistry; 1.3 mRNA (Messenger ribonucleic acids) isolation and
           real time PCR (Polymerase chain reaction);

        2. culturing biopsies

      On the basis of these observations, the general aim of the study is to move a significant
      step forward in the current knowledge on human ENS (enteric nervous system) in IBS by
      establishing a live imaging method to record enteric nerves activity in small intestinal
      biopsies from humans. This development is unique in its kind as not other research groups
      have reported successful live recordings with calcium imaging in this preparation.

      In particular, the investigators aim:

        1. to develop and validate the technique to measure activity in human enteric nerves in the
           submucous plexus isolated from rectal biopsies from healthy subjects and IBS patients;

        2. to characterize this nerve activity in healthy subjects and IBS patients using both
           calcium imaging to evaluate the effect of different neuromodulators,
           immunohistochemistry and rtPCR to determine receptor expression levels and identify
           neurons and glial cells in the submucous ganglia;

        3. to investigate whether the biopsies of IBS patients secrete more modulators/cytokines
           compared to healthy subjects and their potential to activate neurons.

        4. to evaluate the influence of different food constituents (cowâ€Ÿs milk, wheat, yeast,
           gluten and soy) on the local reaction of the rectal mucosa and evaluate mast cell
           activation/degranulation in biopsies of IBS patients compared to healthy subjects.

        5. To evaluate the amount of inflammatory mediators/metabolites in urine samples of IBS
           patients and healthy volunteers by the use of metabolic profiling
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>nerve activity in healthy subjects and IBS patients</measure>
    <time_frame>Starting from the moment biopsies are collected untill nerve activity in samples is lost (approximately 5 hours)</time_frame>
    <description>Measuring nerve activity in healthy subjects and IBS patients using both calcium imaging to evaluate the effect of different neuromodulators, immunohistochemistry and rtPCR to determine receptor expression levels and identify neurons and glial cells in the submucous ganglia.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">99999999</enrollment>
  <condition>IBS</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Rectal biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rectal biopsies from IBS patients or healthy subjects will be taken during proctoscopy</intervention_name>
    <arm_group_label>Rectal biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IBS patients (based on ROME III Criteria)

          -  Healthy subjects

        Exclusion Criteria:

        - All subjects with not IBS related complaints
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guy Boeckxstaens, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catholic University Leuven and Universitary Hospitals Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lien Beullens, MSc</last_name>
    <phone>0032-16-341943</phone>
    <email>lien.beullens@kuleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dafne Balemans, MSc</last_name>
    <phone>0032-16-330158</phone>
    <email>dafne.balemans@med.kuleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lien Beullens, MSc</last_name>
      <phone>0032-16-341943</phone>
      <email>lien.beullens@kuleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Dafne Balemans, MSc</last_name>
      <phone>0032-16-330158</phone>
      <email>dafne.balemans@med.kuleuven.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2013</study_first_submitted>
  <study_first_submitted_qc>July 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2013</study_first_posted>
  <last_update_submitted>February 7, 2017</last_update_submitted>
  <last_update_submitted_qc>February 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Guy Boeckxstaens</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>IBS patients</keyword>
  <keyword>healthy subjects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

